Product NDC: | 68382-261 |
Proprietary Name: | Acetazolamide |
Non Proprietary Name: | Acetazolamide |
Active Ingredient(s): | 500 mg/1 & nbsp; Acetazolamide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68382-261 |
Labeler Name: | Zydus Pharmaceuticals (USA) Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040904 |
Marketing Category: | ANDA |
Start Marketing Date: | 20081215 |
Package NDC: | 68382-261-01 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-261-01) |
NDC Code | 68382-261-01 |
Proprietary Name | Acetazolamide |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-261-01) |
Product NDC | 68382-261 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acetazolamide |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20081215 |
Marketing Category Name | ANDA |
Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
Substance Name | ACETAZOLAMIDE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |